PV

Prajakta Vasantrao Hawaldar

Active Director Director DIN 09371202
DIN 09371202 First appointment Oct 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Prajakta Vasantrao Hawaldar

Data last updated:

Prajakta Vasantrao Hawaldar is a Director at Le Crocus Healthcare Private Limited (since 2021). The company operates in Healthcare.

DIN 09371202
Primary Designation Director
Industry Healthcare
First Appointment 22 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Le Crocus Healthcare Private Limited U85110PN2021PTC205472
Director22 Oct 20212021Active

Board colleagues of Prajakta Vasantrao Hawaldar

Directorship timeline

Open interactive timeline →
Le Crocus Healthcare Private Limited
Premium access

Shareholding and investment profile for Prajakta Vasantrao Hawaldar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prajakta Vasantrao Hawaldar

Prajakta Vasantrao Hawaldar currently holds 1 directorship: Le Crocus Healthcare Private Limited (Director, since 22 Oct 2021).

Prajakta Vasantrao Hawaldar was first appointed on 22 Oct 2021 as Director at Le Crocus Healthcare Private Limited.

The current boards of Prajakta Vasantrao Hawaldar's companies include Ashish Jagannath Jawale (Le Crocus Healthcare Private Limited), Varsha Kundalik Dhaigude (Le Crocus Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available